Kenya trial tests simpler HIV pill for seniors
NCT ID NCT06444620
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This study looks at whether older adults (60+) with HIV can safely switch from their current medication (B/F/TAF) to a simpler two-drug pill (DTG/3TC). About 240 participants in Kenya will be followed for 96 weeks to see if the new pill keeps the virus under control. The goal is to find a treatment that is just as effective but easier to take.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jaramogi Oginga Odinga Teaching and Referral Hospital
Kisumu, Kenya
-
Kenyatta National Hospital
Nairobi, Kenya
Conditions
Explore the condition pages connected to this study.